Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Inghirami

Showing results (191-200 of 240) with videos related to

Pageof 24
Sort By:
Cancer Research|October 6, 2023
XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer CellsRossella Marullo, Sarah C Rutherford, Maria V Revuelta, et al.
Oncoimmunology|April 11, 2018
Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasmsPaola Circosta, Angela Rita Elia, Indira Landra, et al.
Future Oncology (London, England)|July 11, 2026
QuANTUM-Wild: a Phase III, randomized trial of quizartinib in newly diagnosed <i>FLT3</i>-ITD-negative acute myeloid leukemiaPau Montesinos, Jessica K Altman, Lars Bullinger, et al.
The Lancet. Haematology|February 28, 2020
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell ProjectChristopher P Fox, Monica Civallero, Young-Hyeh Ko, et al.
Nature Immunology|October 23, 2023
Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19Takato Kusakabe, Woan-Yu Lin, Jin-Gyu Cheong, et al.
Blood Advances|May 22, 2024
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myelomaMateo Mejia Saldarriaga, Darren Pan, Caitlin Unkenholz, et al.
Hematological Oncology|July 17, 2010
Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcomeEkaterina Chigrinova, Michael Mian, Marta Scandurra, et al.
Blood|September 6, 2013
PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphomaMichela Boi, Andrea Rinaldi, Ivo Kwee, et al.
British Journal of Haematology|October 17, 2009
Genome wide DNA-profiling of HIV-related B-cell lymphomasDaniela Capello, Marta Scandurra, Giulia Poretti, et al.
Haematologica|October 15, 2020
Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohortJohanne M Holst, Trine L Plesner, Martin B Pedersen, et al.
Pageof 24

Showing results (191-200 of 240) with videos related to

Sort By:
Pageof 24
Cancer Research|October 6, 2023
XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer CellsRossella Marullo, Sarah C Rutherford, Maria V Revuelta, et al.
Oncoimmunology|April 11, 2018
Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasmsPaola Circosta, Angela Rita Elia, Indira Landra, et al.
Future Oncology (London, England)|July 11, 2026
QuANTUM-Wild: a Phase III, randomized trial of quizartinib in newly diagnosed <i>FLT3</i>-ITD-negative acute myeloid leukemiaPau Montesinos, Jessica K Altman, Lars Bullinger, et al.
The Lancet. Haematology|February 28, 2020
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell ProjectChristopher P Fox, Monica Civallero, Young-Hyeh Ko, et al.
Nature Immunology|October 23, 2023
Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19Takato Kusakabe, Woan-Yu Lin, Jin-Gyu Cheong, et al.
Blood Advances|May 22, 2024
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myelomaMateo Mejia Saldarriaga, Darren Pan, Caitlin Unkenholz, et al.
Hematological Oncology|July 17, 2010
Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcomeEkaterina Chigrinova, Michael Mian, Marta Scandurra, et al.
Blood|September 6, 2013
PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphomaMichela Boi, Andrea Rinaldi, Ivo Kwee, et al.
British Journal of Haematology|October 17, 2009
Genome wide DNA-profiling of HIV-related B-cell lymphomasDaniela Capello, Marta Scandurra, Giulia Poretti, et al.
Haematologica|October 15, 2020
Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohortJohanne M Holst, Trine L Plesner, Martin B Pedersen, et al.
Pageof 24